Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04624906 |
| Title | Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia (BRAWM) |
| Acronym | BRAWM |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Sunnybrook Health Sciences Centre |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Tom Baker Cancer Centre | Calgary | Alberta | Canada | Details | ||
| Cross Cancer Institute | Edmonton | Alberta | Canada | Details | ||
| Vancouver General Hospital | Vancouver | British Columbia | Canada | Details | ||
| QEII Health Sciences Centre | Halifax | Nova Scotia | Canada | Details | ||
| Hamilton Health Sciences Centre - Juravinksi | Hamilton | Ontario | Canada | Details | ||
| The Ottawa Hospital | Ottawa | Ontario | Canada | Details | ||
| Sunnybrook Health Sciences Centre | Toronto | Ontario | M4N 3M5 | Canada | Details | |
| CHU de Quebec - University Laval | Laval | Quebec | Canada | Details | ||
| McGill University Health Centre | Montréal | Quebec | Canada | Details |